BioGaia AB (publ) (LON:0GTN)

BioGaia AB Statistics

Total Valuation

BioGaia AB has a market cap or net worth of GBP 782.40 million. The enterprise value is 733.97 million.

Market Cap	782.40M
Enterprise Value	733.97M

Important Dates

The last earnings date was Friday, July 18, 2025.

Earnings Date	Jul 18, 2025
Ex-Dividend Date	May 8, 2025

Share Statistics

Current Share Class	97.46M
Shares Outstanding	n/a
Shares Change (YoY)	+0.17%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	70.69M

Valuation Ratios

The trailing PE ratio is 35.56 and the forward PE ratio is 25.95.

PE Ratio	35.56
Forward PE	25.95
PS Ratio	7.08
PB Ratio	8.83
P/TBV Ratio	10.19
P/FCF Ratio	32.83
P/OCF Ratio	32.35
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.00, with an EV/FCF ratio of 30.80.

EV / Earnings	33.36
EV / Sales	6.55
EV / EBITDA	21.00
EV / EBIT	22.29
EV / FCF	30.80

Financial Position

The company has a current ratio of 5.74

Current Ratio	5.74
Quick Ratio	3.45
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	234.96

Financial Efficiency

Return on equity (ROE) is 21.00% and return on invested capital (ROIC) is 19.38%.

Return on Equity (ROE)	21.00%
Return on Assets (ROA)	15.87%
Return on Invested Capital (ROIC)	19.38%
Return on Capital Employed (ROCE)	33.79%
Revenue Per Employee	480,477
Profits Per Employee	95,656
Employee Count	225
Asset Turnover	0.86
Inventory Turnover	n/a

Taxes

In the past 12 months, BioGaia AB has paid 5.92 million in taxes.

Income Tax	5.92M
Effective Tax Rate	21.21%

Stock Price Statistics

The stock price has decreased by -21.04% in the last 52 weeks. The beta is 0.63, so BioGaia AB's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	-21.04%
50-Day Moving Average	103.43
200-Day Moving Average	109.15
Relative Strength Index (RSI)	39.61
Average Volume (20 Days)	35,284

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioGaia AB had revenue of GBP 110.51 million and earned 22.00 million in profits. Earnings per share was 0.22.

Revenue	110.51M
Gross Profit	80.07M
Operating Income	32.48M
Pretax Income	27.92M
Net Income	22.00M
EBITDA	33.80M
EBIT	32.48M
Earnings Per Share (EPS)	0.22

Balance Sheet

The company has 47.77 million in cash and n/a in debt, giving a net cash position of 47.77 million.

Cash & Cash Equivalents	47.77M
Total Debt	n/a
Net Cash	47.77M
Net Cash Per Share	n/a
Equity (Book Value)	88.63M
Book Value Per Share	0.88
Working Capital	65.53M

Cash Flow

In the last 12 months, operating cash flow was 24.18 million and capital expenditures -348,472, giving a free cash flow of 23.83 million.

Operating Cash Flow	24.18M
Capital Expenditures	-348,472
Free Cash Flow	23.83M
FCF Per Share	n/a

Margins

Gross margin is 72.45%, with operating and profit margins of 29.39% and 19.91%.

Gross Margin	72.45%
Operating Margin	29.39%
Pretax Margin	25.27%
Profit Margin	19.91%
EBITDA Margin	30.58%
EBIT Margin	29.39%
FCF Margin	21.57%

Dividends & Yields

This stock pays an annual dividend of 0.54, which amounts to a dividend yield of 0.54%.

Dividend Per Share	0.54
Dividend Yield	0.54%
Dividend Growth (YoY)	5.77%
Years of Dividend Growth	1
Payout Ratio	67.37%
Buyback Yield	-0.17%
Shareholder Yield	0.37%
Earnings Yield	2.81%
FCF Yield	3.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.

Last Split Date	May 18, 2022
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	5